US5187193A
(en)
*
|
1988-09-12 |
1993-02-16 |
University Of Rochester |
Method for stimulating transplanted bone marrow cells
|
AU6647190A
(en)
*
|
1989-10-10 |
1991-05-16 |
University Of Rochester |
Method for producing bone marrow growth cell factors
|
JPH06509578A
(ja)
*
|
1991-07-26 |
1994-10-27 |
ユニバーシティ・オブ・ロチェスター |
悪性細胞利用による癌治療法
|
US5240914A
(en)
*
|
1992-02-03 |
1993-08-31 |
Adolph Schwimmer |
Method and compositions for inhibiting tumor cell metabolism
|
US6448235B1
(en)
|
1994-07-11 |
2002-09-10 |
University Of Virginia Patent Foundation |
Method for treating restenosis with A2A adenosine receptor agonists
|
US6514949B1
(en)
|
1994-07-11 |
2003-02-04 |
University Of Virginia Patent Foundation |
Method compositions for treating the inflammatory response
|
US7135584B2
(en)
*
|
1995-08-07 |
2006-11-14 |
Wake Forest University |
Lipid analogs for treating viral infections
|
JP4259611B2
(ja)
|
1994-08-29 |
2009-04-30 |
ウェイク フォレスト ユニバーシティ |
ウィルス感染を治療するための脂質アナログ
|
US5807874A
(en)
*
|
1995-05-17 |
1998-09-15 |
Rutgers, The State University Of New Jersey |
Trisbenzimidazoles useful as topoisomerase I inhibitors
|
US5767142A
(en)
*
|
1996-03-20 |
1998-06-16 |
Rutgers, The State University Of New Jersey |
Trisbenzimidazoles useful as topoisomerase I inhibitors
|
US5616575A
(en)
*
|
1995-12-04 |
1997-04-01 |
Regents Of The University Of Minnesota |
Bioactive tricyclic ibogaine analogs
|
US5932553A
(en)
|
1996-07-18 |
1999-08-03 |
The Regents Of The University Of California |
Illudin analogs useful as antitumor agents
|
US5723632A
(en)
|
1996-08-08 |
1998-03-03 |
Mgi Pharma, Inc. |
Total synthesis of antitumor acylfulvenes
|
US5922761A
(en)
*
|
1996-09-06 |
1999-07-13 |
Medinox, Inc. |
Methods for in vivo reduction of iron levels and compositions useful therefor
|
NZ334954A
(en)
*
|
1996-09-23 |
2000-08-25 |
Univ Rutgers |
Substituted heterocycles as anti-tumor agents
|
US5916903A
(en)
*
|
1997-02-28 |
1999-06-29 |
Synapse Pahrmaceuticals International, Inc. |
Method for reducing the effects of antineoplastic disease treatment
|
US5866558A
(en)
*
|
1997-05-08 |
1999-02-02 |
Regents Of The University Of Minnesota |
6-alkynyl steroids
|
US6486214B1
(en)
*
|
1997-09-10 |
2002-11-26 |
Rutgers, The State University Of New Jersey |
Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
|
US6468519B1
(en)
*
|
1997-09-10 |
2002-10-22 |
Rutgers, The State University Of New Jersey |
Polyanhydrides with biologically active degradation products
|
US6140328A
(en)
*
|
1997-12-12 |
2000-10-31 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
JP3866298B2
(ja)
*
|
1997-12-29 |
2007-01-10 |
リサーチ コーポレイション テクノロジーズ,インコーポレイティド |
β−ラクタマーゼインヒビターとしての2β−置換化−6−アルキリデンペニシラン酸誘導体
|
US6051603A
(en)
*
|
1998-01-20 |
2000-04-18 |
Wayne Hughes Institute |
Vanadium (IV) metallocene complexes having sperm motility inhibiting activity
|
US6245808B1
(en)
|
1998-11-05 |
2001-06-12 |
Parker Hughes Institute |
Oxy-vanadium (IV) complexes having spermicidal activity
|
US6432941B1
(en)
*
|
1998-01-20 |
2002-08-13 |
Parker Hughes Institute |
Vanadium compounds for treating cancer
|
IL137351A0
(en)
|
1998-02-12 |
2001-07-24 |
Univ Rutgers |
Heterocyclic topoisomerase poisons
|
US7141603B2
(en)
*
|
1999-02-19 |
2006-11-28 |
The Regents Of The University California |
Antitumor agents
|
US6025328A
(en)
|
1998-02-20 |
2000-02-15 |
The Regents Of The University Of California |
Antitumor agents
|
US6117878A
(en)
*
|
1998-02-24 |
2000-09-12 |
University Of Virginia |
8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
|
US6355678B1
(en)
*
|
1998-06-29 |
2002-03-12 |
Parker Hughes Institute |
Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
|
US6800649B1
(en)
|
1998-06-30 |
2004-10-05 |
Parker Hughes Institute |
Method for inhibiting c-jun expression using JAK-3 inhibitors
|
US6323190B1
(en)
|
1998-07-31 |
2001-11-27 |
The Univeristy Of Georgia Research Foundation, Inc. |
Estrogen mimetics lacking reproductive tract effects
|
US7214665B2
(en)
*
|
2001-10-01 |
2007-05-08 |
University Of Virginia Patent Foundation |
2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
|
US7378400B2
(en)
*
|
1999-02-01 |
2008-05-27 |
University Of Virginia Patent Foundation |
Method to reduce an inflammatory response from arthritis
|
US7427606B2
(en)
*
|
1999-02-01 |
2008-09-23 |
University Of Virginia Patent Foundation |
Method to reduce inflammatory response in transplanted tissue
|
US6232297B1
(en)
|
1999-02-01 |
2001-05-15 |
University Of Virginia Patent Foundation |
Methods and compositions for treating inflammatory response
|
US6166003A
(en)
*
|
1999-02-17 |
2000-12-26 |
Lkt Laboratories, Inc. |
Heterocyclic compounds for cancer chemoprevention
|
US6638518B1
(en)
|
1999-02-22 |
2003-10-28 |
University Of Iowa Research Foundation |
Method for inhibiting inflammatory responses
|
US6080747A
(en)
*
|
1999-03-05 |
2000-06-27 |
Hughes Institute |
JAK-3 inhibitors for treating allergic disorders
|
DK1159279T3
(da)
|
1999-03-09 |
2003-02-17 |
Upjohn Co |
4-Oxo-4,7-dihydro-thieno[2,3-b]pyridin-5-carboxamider som antivirale midler
|
US6258820B1
(en)
|
1999-03-19 |
2001-07-10 |
Parker Hughes Institute |
Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
|
US7064114B2
(en)
*
|
1999-03-19 |
2006-06-20 |
Parker Hughes Institute |
Gel-microemulsion formulations
|
US6306897B1
(en)
|
1999-03-19 |
2001-10-23 |
Parker Hughes Institute |
Calanolides for inhibiting BTK
|
US6407091B1
(en)
*
|
1999-04-15 |
2002-06-18 |
Research Corporation Technologies, Inc. |
β-lactamase inhibiting compounds
|
US6930101B1
(en)
|
1999-05-17 |
2005-08-16 |
The Regents Of The University Of California |
Thiazolopyrimidines useful as TNFα inhibitors
|
US6322771B1
(en)
|
1999-06-18 |
2001-11-27 |
University Of Virginia Patent Foundation |
Induction of pharmacological stress with adenosine receptor agonists
|
AU5630800A
(en)
*
|
1999-06-22 |
2001-01-09 |
Arno F Spatola |
Antimicrobial agents
|
US6946458B2
(en)
|
1999-07-22 |
2005-09-20 |
University Of South Florida |
N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant Staphylococcus aureus
|
US7151100B1
(en)
*
|
1999-07-23 |
2006-12-19 |
The Regents Of The University Of California |
Indole compounds useful for the treatment of cancer
|
US6852685B1
(en)
|
1999-08-17 |
2005-02-08 |
Board Of Regents, The University Of Texas System |
Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neuronal cell differentiation
|
US7119064B2
(en)
*
|
1999-08-17 |
2006-10-10 |
Board Of Regents, The University Of Texas System |
Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules
|
EP1218018A4
(de)
*
|
1999-08-17 |
2005-06-01 |
Univ Texas |
Verwendung von colostrinin, seine peptidbestandteile und ihre analogen als regulatoren bei oxidativem stress
|
US6903068B1
(en)
|
1999-08-17 |
2005-06-07 |
Board Of Regents, The University Of Texas System |
Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines
|
MY125942A
(en)
|
1999-09-07 |
2006-09-29 |
Upjohn Co |
Aminoalkoxy carbazoles for the treatment of cns diseases
|
US7026469B2
(en)
*
|
2000-10-19 |
2006-04-11 |
Wake Forest University School Of Medicine |
Compositions and methods of double-targeting virus infections and cancer cells
|
US6670341B1
(en)
|
1999-10-28 |
2003-12-30 |
Wake Forest University Health Sciences |
Compositions and methods for double-targeting virus infections and targeting cancer cells
|
US6740650B2
(en)
|
1999-10-29 |
2004-05-25 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
AU1608801A
(en)
|
1999-11-15 |
2001-05-30 |
Parker Hughes Institute |
Diamino platinum (ii) antitumor complexes
|
US6649654B1
(en)
|
1999-11-23 |
2003-11-18 |
The Regents Of The University Of California |
Methods for identifying and using IKK inhibitors
|
US6589992B2
(en)
|
1999-11-30 |
2003-07-08 |
Parker Hughes Institute |
Inhibiting collagen-induced platelet aggregation
|
US20040038948A1
(en)
|
1999-12-07 |
2004-02-26 |
Uhrich Kathryn E. |
Therapeutic compositions and methods
|
US6685928B2
(en)
|
1999-12-07 |
2004-02-03 |
Rutgers, The State University Of New Jersey |
Therapeutic compositions and methods
|
ATE316097T1
(de)
*
|
2000-01-20 |
2006-02-15 |
Univ Minnesota |
Peptide mit antibakterieller wirkung
|
JP2003529601A
(ja)
|
2000-03-21 |
2003-10-07 |
ファルマシア・アンド・アップジョン・カンパニー |
抗ウイルス剤としての4−オキソ−1,4−ジヒドロ[1,8]ナフチリジン−3−カルボキサミド
|
MXPA02009250A
(es)
|
2000-03-21 |
2003-03-12 |
Upjohn Co |
4-hidroxi-1,8-naftiridin--3-carboxamidas como agentes antivirales.
|
WO2001081318A1
(en)
|
2000-03-21 |
2001-11-01 |
Pharmacia & Upjohn Company |
4-hydroxycinnoline-3-carboxyamides as antiviral agents
|
US6682892B2
(en)
|
2000-07-13 |
2004-01-27 |
Pharmacia & Upjohn Company |
Method for treating herpes viruses
|
US20040152672A1
(en)
*
|
2000-08-09 |
2004-08-05 |
Carson Dennis A. |
Indole compounds useful for the treatment of cancer
|
US6696441B1
(en)
|
2000-08-11 |
2004-02-24 |
The Regents Of The University Of California |
Inhibition of p53-induced stress response
|
WO2002026762A1
(en)
*
|
2000-09-29 |
2002-04-04 |
Regents Of The University Of Minnesota |
Triterpenes having antibacterial activity
|
US6951847B2
(en)
*
|
2000-09-29 |
2005-10-04 |
Regents Of The University Of Minnesota |
Methods of treating fungal infections using lupeol
|
US6642217B2
(en)
|
2000-09-29 |
2003-11-04 |
Naturtek, Llc |
Triterpenes having human antifungal and antiyeast activity
|
US7309696B2
(en)
|
2000-10-19 |
2007-12-18 |
Wake Forest University |
Compositions and methods for targeting cancer cells
|
US6878388B1
(en)
|
2000-11-15 |
2005-04-12 |
Parker Hughes Institute |
Vanadium compounds for treating proliferative cell disorders
|
US6642221B1
(en)
|
2000-11-15 |
2003-11-04 |
Parker Hughes Institute |
Vanadium compounds as anti-proliferative agents
|
US6958359B1
(en)
*
|
2000-11-15 |
2005-10-25 |
Parker Hughes Institute |
Vanadium compounds as anti-angiogenic agents
|
AU2002249885A1
(en)
|
2000-11-17 |
2002-08-12 |
Adolor Corporation |
Delta agonist analgesics
|
US20040034045A1
(en)
*
|
2000-11-29 |
2004-02-19 |
Parker Hughes Institute |
Inhibitors of thrombin induced platelet aggregation
|
US7261901B2
(en)
*
|
2001-01-31 |
2007-08-28 |
University Of Iowa Research Foundation |
Vaccine and compositions for the prevention and treatment of neisserial infections
|
US7250172B2
(en)
*
|
2001-01-31 |
2007-07-31 |
University Of Iowa Research Foundation |
Vaccine and compositions for the prevention and treatment of neisserial infections
|
US6703524B2
(en)
|
2001-02-20 |
2004-03-09 |
Lkt Laboratories, Inc. |
Organoselenium compounds for cancer chemoprevention
|
US7232829B2
(en)
*
|
2001-04-06 |
2007-06-19 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
GB0111872D0
(en)
*
|
2001-05-15 |
2001-07-04 |
Northwick Park Inst For Medica |
Therapeutic agents and methods
|
CN1486289A
(zh)
*
|
2001-05-29 |
2004-03-31 |
皇家菲利浦电子有限公司 |
金属-陶瓷的结合
|
US20030232794A1
(en)
*
|
2001-06-26 |
2003-12-18 |
Cottam Howard B. |
Use of STAT-6 inhibitors as therapeutic agents
|
US7601846B2
(en)
*
|
2001-06-26 |
2009-10-13 |
The Regents Of The University Of California |
Compounds having activity as inhibitors of apoptosis
|
JP2005502687A
(ja)
*
|
2001-07-24 |
2005-01-27 |
アラムクス エルエルシー |
β−ラクタマーゼ阻害剤としての7−アルキリデン−3−置換型−3−セフェム−4−カルボキシラート
|
US6753414B2
(en)
*
|
2001-08-07 |
2004-06-22 |
University Of Iowa Research Foundation, Inc. |
Process for preparing saponin compounds
|
JP2005526691A
(ja)
|
2001-08-08 |
2005-09-08 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
治療剤1H−ピリド[4,3−b]インドール
|
US20030171377A1
(en)
*
|
2001-08-29 |
2003-09-11 |
Bigge Christopher Franklin |
Antidiabetic agents
|
WO2003020728A1
(en)
|
2001-08-30 |
2003-03-13 |
Pharmacia & Upjohn Company |
4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS
|
IL160080A0
(en)
*
|
2001-08-31 |
2004-06-20 |
Thomson Licensing Sa |
Sequence counter for an audio visual stream
|
BR0212676A
(pt)
*
|
2001-09-21 |
2006-05-23 |
Upjohn Co |
compostos terapêuticos ligantes de 5-ht, composições farmacêuticas compreendendo tais compostos e seus usos
|
US6815555B2
(en)
|
2001-09-26 |
2004-11-09 |
Theravance, Inc. |
Substituted phenol compounds useful for anesthesia and sedation
|
WO2003031587A2
(en)
*
|
2001-10-09 |
2003-04-17 |
The Regents Of The University Of California |
Use of stat-6 inhibitors as therapeutic agents
|
DE60238435D1
(de)
*
|
2001-10-26 |
2011-01-05 |
Scripps Research Inst |
Gezielte thrombose durch gewebefaktor polypeptiden
|
CA2467774C
(en)
|
2001-11-14 |
2011-09-20 |
Rutgers, The State University |
Solubilized topoisomerase poisons
|
DE60228484D1
(de)
*
|
2001-11-14 |
2008-10-02 |
Univ Rutgers |
Cytotoxische mittel
|
MXPA04004701A
(es)
*
|
2001-11-23 |
2005-07-01 |
Univ Rutgers |
Sintesis mejorada de polianhidridos.
|
US7030141B2
(en)
*
|
2001-11-29 |
2006-04-18 |
Christopher Franklin Bigge |
Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
|
AU2003205332A1
(en)
*
|
2002-01-25 |
2003-09-02 |
Philip S. Portoghese |
Selective analgesic agents
|
JP2005519928A
(ja)
*
|
2002-02-04 |
2005-07-07 |
ハース,ベルナー |
Co放出能力を有する化合物の投与によって哺乳動物を治療する方法と、co放出能力を有する化合物ならびにその医薬組成物
|
US20080026984A1
(en)
*
|
2002-02-04 |
2008-01-31 |
Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda |
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
|
US7968605B2
(en)
*
|
2002-02-04 |
2011-06-28 |
ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. |
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
|
CA2475187A1
(en)
|
2002-02-07 |
2003-08-14 |
Rutgers, The State University Of New Jersey |
Therapeutic polyesters and polyamides
|
WO2003072053A2
(en)
|
2002-02-22 |
2003-09-04 |
The Curators Of The University Of Missouri |
Compounds for treatment of copper overload
|
US20050032713A1
(en)
*
|
2002-03-27 |
2005-02-10 |
Wurtman Richard J. |
Platelet-activating factor antagonists as analgesic, anti-inflammatory, uterine contraction inhibiting, and anti-tumor agents
|
AU2003224874A1
(en)
*
|
2002-04-04 |
2003-10-27 |
Alamx, L.L.C. |
INHIBITORS OF SERINE AND METALLO-ss-LACTAMASES
|
JP4651946B2
(ja)
*
|
2002-04-25 |
2011-03-16 |
ザ スクリプス リサーチ インスティテュート |
肺病態の治療および予防
|
US7026472B2
(en)
*
|
2002-05-06 |
2006-04-11 |
University Of South Florida |
Methods for preventing and treating cancer using N-thiolated β-lactam compounds and analogs thereof
|
US20040156799A1
(en)
*
|
2002-06-04 |
2004-08-12 |
Zigang Dong |
Cancer treatment method and compositions
|
UA79293C2
(en)
*
|
2002-07-03 |
2007-06-11 |
Univ Wayne State |
4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents
|
WO2004004640A2
(en)
*
|
2002-07-05 |
2004-01-15 |
Tetragrammaton Inc. |
Methods, compositions and kits for treating damage to excitable tissue
|
US6989387B2
(en)
*
|
2002-08-09 |
2006-01-24 |
Rutgers, The State University Of New Jersey |
Nitro and amino substituted topoisomerase agents
|
JP2005538175A
(ja)
*
|
2002-09-11 |
2005-12-15 |
ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー |
血液凝固過程に関与する第Xa因子および他セリンプロテアーゼのインヒビター
|
WO2004026116A2
(en)
*
|
2002-09-19 |
2004-04-01 |
The Regents Of The University Of California |
Use of etodoclac to treat hyperplasia
|
WO2004032599A2
(en)
|
2002-10-10 |
2004-04-22 |
Cornell Research Foundation, Inc. |
Novel immunogenic proteins of leptospira
|
US20060183106A1
(en)
*
|
2002-10-18 |
2006-08-17 |
Adam Siddiqui-Jain |
Processes for identifying quadruplex-targeted antiviral molecules
|
EP1567551A4
(de)
*
|
2002-10-22 |
2008-03-12 |
Univ Texas |
Colostrinin und darin enthaltende peptide als modulatoren von intrazellulären signal-molekülen und apoptose-inhibitoren
|
BR0306632A
(pt)
*
|
2002-10-28 |
2004-09-28 |
Paraquest Inc |
Hipoestóxidos, seus derivados e agonistas para uso no tratamento e profilaxia de hiperlipidemia
|
WO2004041865A2
(en)
|
2002-11-08 |
2004-05-21 |
Ablynx N.V. |
Stabilized single domain antibodies
|
AU2003286004A1
(en)
|
2002-11-08 |
2004-06-07 |
Ablynx N.V. |
Single domain antibodies directed against interferon- gamma and uses therefor
|
GB2395432B
(en)
*
|
2002-11-20 |
2005-09-14 |
Northwick Park Inst For Medica |
Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
|
EP1565165A2
(de)
*
|
2002-11-26 |
2005-08-24 |
Gilead Sciences, Inc. |
Liposomzubereitungen
|
US8119854B2
(en)
*
|
2002-12-10 |
2012-02-21 |
Pietro P. Sanna |
Role of proteoglycans in drug dependence
|
EP1581634A4
(de)
*
|
2002-12-10 |
2006-10-25 |
Scripps Research Inst |
Verfahren zur behandlung von drogensucht und zum screening von pharmazeutika dafür
|
US7297340B2
(en)
*
|
2003-01-07 |
2007-11-20 |
University Of Iowa Research Foundation |
Vaccine and method for preventing biofilm formation
|
CA2512545C
(en)
|
2003-01-10 |
2015-06-30 |
Karen Silence |
Recombinant vhh single domain antibody from camelidae against von willebrand factor (vwf)
|
US20050079512A1
(en)
*
|
2003-02-26 |
2005-04-14 |
Emerson Beverly M. |
Methods of modulating gene expression
|
JP4928937B2
(ja)
|
2003-03-28 |
2012-05-09 |
スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ |
ミグラスタチンアナログおよびその使用
|
US7354916B2
(en)
*
|
2003-04-07 |
2008-04-08 |
Cylene Pharmaceuticals |
Substituted quinobenzoxazine analogs
|
BRPI0409105A
(pt)
*
|
2003-04-07 |
2006-04-25 |
Cylene Pharmaceuticals Inc |
análogos de quinobenzoxazina substituìdos
|
US7507727B2
(en)
*
|
2003-04-07 |
2009-03-24 |
Cylene Pharmaceuticals, Inc. |
Substituted quinobenzoxazine analogs and methods of using thereof
|
US7163948B2
(en)
*
|
2003-04-07 |
2007-01-16 |
Cylene Pharmaceuticals, Inc. |
Heterocyclic substituted 1,4-dihydri-4ox9-1,8-naphthyridine analogs
|
US20040248880A1
(en)
*
|
2003-04-25 |
2004-12-09 |
Jacobsen Eric Jon |
1,2,3,4,5,6-Hexahydroazepino[4,5-B]indoles containing arylsulfones at the 9-position
|
EP1635858A4
(de)
*
|
2003-05-29 |
2009-08-26 |
Scripps Research Inst |
Gezielte abgabe an legumain exprimierende zellen
|
CA2529507C
(en)
|
2003-06-25 |
2011-08-09 |
The Burnham Institute |
Compounds and methods for inducing apoptosis in cancer cells
|
WO2005003140A1
(en)
*
|
2003-07-02 |
2005-01-13 |
Pharmacia & Upjohn Company Llc |
4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents
|
EP2295434B1
(de)
|
2003-08-25 |
2015-09-30 |
Dogwood Pharmaceuticals, Inc. |
Substituierte 8-Heteroaryl-Xanthine
|
PL2520654T3
(pl)
|
2003-08-26 |
2017-08-31 |
The Regents Of The University Of Colorado, A Body Corporate |
Inhibitory aktywności proteazy serynowej i ich zastosowanie w sposobach i kompozycjach do leczenia zakażeń bakteryjnych
|
US9532994B2
(en)
|
2003-08-29 |
2017-01-03 |
The Regents Of The University Of California |
Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
|
US20050118678A1
(en)
*
|
2003-10-17 |
2005-06-02 |
Regents Of The University Of Minnesota |
Modified polypeptides with therapeutic activity and methods of use
|
EP2251357A1
(de)
|
2003-11-07 |
2010-11-17 |
Ablynx N.V. |
Camelidae schweren Ketten Antikörpern VHHS gegen Epidermal Growth Faktor Rezeptor (EGFR) und Ihre Verwendungen
|
WO2005055994A1
(en)
*
|
2003-12-04 |
2005-06-23 |
The Scripps Research Institute |
Treatment and preventions of asthma
|
EP2299266A1
(de)
*
|
2003-12-19 |
2011-03-23 |
The Regents of the University of California |
Verfahren und Materialien zur Beurteilung von Prostatakrebstherapien
|
NZ548195A
(en)
|
2004-01-14 |
2011-01-28 |
Gilead Sciences Inc |
Lipid-based dispersions useful for drug delivery
|
WO2005072766A2
(en)
*
|
2004-01-27 |
2005-08-11 |
Boys Town National Research Hospital |
Peptides that bind to hsp90 proteins
|
US8841326B2
(en)
|
2004-02-12 |
2014-09-23 |
Stc.Unm |
Therapeutic curcumin derivatives
|
US20050187192A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Pharmaceutical Company |
Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
|
US20050187191A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Louis S. |
Methods and compositions for the treatment of respiratory syncytial virus
|
US7718684B2
(en)
*
|
2004-02-24 |
2010-05-18 |
The Regents Of The University Of California |
Methods and materials for assessing prostate cancer therapies and compounds
|
EP1737472B1
(de)
|
2004-03-29 |
2014-08-13 |
University Of South Florida |
Wirksame Behandlung von Tumoren und Krebs mit Triciribin
|
US8957056B2
(en)
*
|
2004-05-25 |
2015-02-17 |
Sloan-Kettering Instiute For Cancer Research |
Migrastatin analogs in the treatment of cancer
|
EP1778712B1
(de)
*
|
2004-08-02 |
2013-01-30 |
University Of Virginia Patent Foundation |
2-propynyl-adenosin-analoga mit modifizierten 5'-ribosegruppen mit a2a-agonistenaktivität
|
WO2006028618A1
(en)
*
|
2004-08-02 |
2006-03-16 |
University Of Virginia Patent Foundation |
2-polycyclic propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
|
US7442687B2
(en)
*
|
2004-08-02 |
2008-10-28 |
The University Of Virginia Patent Foundation |
2-polycyclic propynyl adenosine analogs having A2A agonist activity
|
WO2006026380A2
(en)
*
|
2004-08-25 |
2006-03-09 |
University Of Iowa Research Foundation |
Geranylgeranyl pyrophosphate synthase inhibitors
|
JP4950890B2
(ja)
*
|
2004-09-13 |
2012-06-13 |
ギリアード サイエンシーズ, インコーポレイテッド |
動物に対する鉄の送達
|
US7718680B2
(en)
*
|
2004-09-23 |
2010-05-18 |
Burnham Institute For Medical Research |
Inhibition of lethal factor protease activity from anthrax toxin
|
US8188141B2
(en)
*
|
2004-09-23 |
2012-05-29 |
Sloan-Kettering Institute For Cancer Research |
Isomigrastatin analogs in the treatment of cancer
|
CA2583017A1
(en)
*
|
2004-10-13 |
2006-04-20 |
Ablynx N.V. |
Single domain camelide anti-amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenerative neural diseases such as alzheimer's disease
|
US8697674B2
(en)
*
|
2004-12-29 |
2014-04-15 |
Naturon, Inc. |
Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
|
EP1845778A2
(de)
*
|
2005-01-10 |
2007-10-24 |
University Of Virginia Patent Foundation |
Synthese von p90rsk-hemmern
|
US7691364B2
(en)
*
|
2005-01-28 |
2010-04-06 |
Bezwada Biomedical, Llc |
Functionalized drugs and polymers derived therefrom
|
DK2444085T3
(en)
|
2005-05-13 |
2015-04-27 |
Univ California |
Diarylhydantoinforbindelser as androgenreceptorantagonister for treating cancer
|
US7709517B2
(en)
*
|
2005-05-13 |
2010-05-04 |
The Regents Of The University Of California |
Diarylhydantoin compounds
|
EP2365000A3
(de)
|
2005-05-18 |
2013-01-16 |
Ablynx N.V. |
Verbesserte Nanokörper-TM gegen Tumornekrosefaktor Alpha
|
PL3415535T3
(pl)
|
2005-05-20 |
2021-06-14 |
Ablynx N.V. |
Ulepszone Nanociała TM do leczenia zaburzeń, w których pośredniczy agregacja
|
US20070025910A1
(en)
|
2005-07-29 |
2007-02-01 |
Norenberg Jeffrey P |
Anticancer therapy
|
JP4989648B2
(ja)
*
|
2005-08-03 |
2012-08-01 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
抗癌剤として有用なイルジン類似体
|
JP2009504803A
(ja)
|
2005-08-22 |
2009-02-05 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
Tlrアゴニスト
|
CA2618970C
(en)
|
2005-08-29 |
2015-03-31 |
University Of Virginia Patent Foundation |
Lisofylline analogs and methods for use
|
US8871764B2
(en)
|
2005-08-29 |
2014-10-28 |
University Of Virginia Patent Foundation |
Lisofylline analogs and methods for use
|
WO2007053794A2
(en)
|
2005-10-21 |
2007-05-10 |
Bezwada Biomedical Llc |
Functionalized phenolic compounds and absorbable therefrom
|
WO2007056113A2
(en)
*
|
2005-11-02 |
2007-05-18 |
Cylene Pharmaceuticals, Inc. |
Methods for targeting quadruplex sequences
|
CN101374856A
(zh)
*
|
2005-11-29 |
2009-02-25 |
斯克里普斯研究学院 |
抑制肿瘤细胞浸润、转移和血管生成
|
US8007526B2
(en)
|
2005-12-01 |
2011-08-30 |
Bezwada Biomedical, Llc |
Difunctionalized aromatic compounds and polymers therefrom
|
WO2007078615A2
(en)
*
|
2005-12-15 |
2007-07-12 |
Cavit Sciences, Inc |
Methods and compositions for treatment of cancer
|
WO2007073226A1
(en)
*
|
2005-12-20 |
2007-06-28 |
Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda |
Method for treating a mammal by administration of a compound having the ability to release co
|
US20070244057A1
(en)
*
|
2006-01-20 |
2007-10-18 |
Henry Paulson |
Suppressing polyglutamine aggregation and toxicity
|
GB0601394D0
(en)
|
2006-01-24 |
2006-03-01 |
Hemocorm Ltd |
Therapeutic delivery of carbon monoxide
|
US7615649B2
(en)
*
|
2006-01-26 |
2009-11-10 |
Iowa State University Research Foundation, Inc, |
Synthesis of polycyclic procyanidins
|
US8178509B2
(en)
*
|
2006-02-10 |
2012-05-15 |
University Of Virginia Patent Foundation |
Method to treat sickle cell disease
|
US20080009545A1
(en)
*
|
2006-02-21 |
2008-01-10 |
The Ohio State University Research Foundation |
Anticancer agents
|
WO2007098281A2
(en)
|
2006-02-27 |
2007-08-30 |
Regents Of The University Of California |
Oxysterol compounds and the hedgehog pathway
|
AU2007221020B9
(en)
|
2006-02-28 |
2013-04-04 |
Dart Neuroscience (Cayman) Ltd. |
Therapeutic compounds
|
CN101431996A
(zh)
*
|
2006-03-22 |
2009-05-13 |
加利福尼亚大学董事会 |
蛋白质异戊二烯基转移酶的抑制剂
|
DK2656841T3
(en)
|
2006-03-27 |
2016-12-05 |
Univ California |
Androgen receptor MODULATOR FOR THE TREATMENT OF PROSTATE CANCER AND androgen receptor-ASSOCIATED DISEASES
|
RU2449993C2
(ru)
|
2006-03-29 |
2012-05-10 |
Те Риджентс Оф Те Юниверсити Оф Калифорния |
Диарилтиогидантоиновые соединения
|
US8093235B2
(en)
|
2006-04-25 |
2012-01-10 |
Rutgers, The State University Of New Jersey |
Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA
|
US8426568B2
(en)
*
|
2006-05-22 |
2013-04-23 |
University Of Virginia Patent Foundation |
Rhamnose substituents of SL0101 and therapeutic uses thereof
|
WO2007142755A2
(en)
|
2006-05-31 |
2007-12-13 |
The Regents Of The University Of California |
Purine analogs
|
ES2414205T3
(es)
*
|
2006-06-02 |
2013-07-18 |
The Ohio State University Research Foundation |
Agentes terapéuticos para el tratamiento de linfoma de células del manto
|
US20110112086A1
(en)
*
|
2006-06-08 |
2011-05-12 |
Cylene Pharmaceuticals, Inc. |
Pyridinone analogs
|
WO2007146831A2
(en)
*
|
2006-06-08 |
2007-12-21 |
Cylene Pharmaceuticals, Inc. |
Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide
|
CN101466382A
(zh)
|
2006-06-16 |
2009-06-24 |
PGx健康有限责任公司 |
取代的8-[6-氨基-3-吡啶基]黄嘌呤
|
US8188063B2
(en)
*
|
2006-06-19 |
2012-05-29 |
University Of Virginia Patent Foundation |
Use of adenosine A2A modulators to treat spinal cord injury
|
WO2008034019A2
(en)
|
2006-09-13 |
2008-03-20 |
Polymerix Corporation |
Active agents and their oligomers and polymers
|
WO2008036244A1
(en)
*
|
2006-09-18 |
2008-03-27 |
The Burham Institute For Medical Research |
Use of cyclosporin a to sensitize resistant cancer cells to death receptor ligands
|
US8022246B2
(en)
*
|
2006-10-10 |
2011-09-20 |
The Burnham Institute For Medical Research |
Neuroprotective compositions and methods
|
US8034829B2
(en)
|
2006-11-17 |
2011-10-11 |
Rexahn Pharmaceuticals, Inc. |
5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives and therapeutic use thereof
|
JP2010511034A
(ja)
*
|
2006-11-29 |
2010-04-08 |
ファイザー・プロダクツ・インク |
第Xa因子阻害剤としての(R)−5−メチル−4,5−ジヒドロ−ピラゾール−1,5−ジカルボン酸1−[(4−クロロ−フェニル)−アミド]5−{[2−フルオロ−4−(2−オキソ−2H−ピリジン−1−イル)−フェニル]−アミド}
|
EP2557090A3
(de)
|
2006-12-19 |
2013-05-29 |
Ablynx N.V. |
Gegen GPCRs gerichtete Aminosäuresequenzen und Polypeptide damit zur Behandlung von Krankheiten und Störungen im Zusammenhang mit GPCR
|
WO2008074840A2
(en)
|
2006-12-19 |
2008-06-26 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
|
JP2010518108A
(ja)
|
2007-02-06 |
2010-05-27 |
ユニバーシティ オブ ルーイビル リサーチ ファウンデーション,インコーポレーテッド |
治療化合物
|
CN101790380B
(zh)
|
2007-02-07 |
2013-07-10 |
加利福尼亚大学董事会 |
合成tlr激动剂的缀合物及其应用
|
WO2008103818A1
(en)
*
|
2007-02-21 |
2008-08-28 |
University Of Louisville Research Foundation |
Therapeutic cotinine compositions
|
CA2679301C
(en)
|
2007-02-28 |
2015-08-11 |
University Of Virginia Patent Foundation |
Lisofylline analogs and methods for use in protecting pancreatic .beta.-cells, treating type 1 diabetes, and treating inflammatory and autoimmune diseases
|
WO2008138001A2
(en)
|
2007-05-08 |
2008-11-13 |
University Of Louisville Research Foundation |
Synthetic peptides and peptide mimetics
|
BRPI0815563A2
(pt)
|
2007-07-12 |
2015-02-18 |
Univ South Florida |
Inibidores de akt/pkb com atividade antitumoral
|
JP2010535204A
(ja)
|
2007-08-02 |
2010-11-18 |
ラトガーズ, ザ ステイト ユニバーシティ オブ ニュー ジャージー |
治療用化合物
|
WO2009025797A1
(en)
*
|
2007-08-16 |
2009-02-26 |
Burnham Institute For Medical Research |
Compositions and methods for treating symptoms of aging
|
WO2009029632A1
(en)
|
2007-08-27 |
2009-03-05 |
Helicon Therapeutics, Inc. |
Therapeutic isoxazole compounds
|
US8217134B2
(en)
|
2007-08-30 |
2012-07-10 |
Bezwada Biomedical, Llc |
Controlled release of biologically active compounds
|
US8048980B2
(en)
|
2007-09-17 |
2011-11-01 |
Bezwada Biomedical, Llc |
Hydrolysable linkers and cross-linkers for absorbable polymers
|
WO2009046383A1
(en)
|
2007-10-05 |
2009-04-09 |
Cylene Pharmaceuticals, Inc. |
Quinolone analogs and methods related thereto
|
CN101896068A
(zh)
*
|
2007-10-19 |
2010-11-24 |
伯恩哈姆医学研究协会 |
抗凋亡蛋白的萘基抑制剂
|
WO2009055677A1
(en)
*
|
2007-10-24 |
2009-04-30 |
University Of South Florida |
Antibacterial s-heterosubstituted disulfides
|
CA2966280A1
(en)
|
2007-10-26 |
2009-04-30 |
The Regents Of The University Of California |
Diarylhydantoin compounds
|
US7951832B2
(en)
*
|
2007-10-31 |
2011-05-31 |
Burnham Institute For Medical Research |
Pyrazole derivatives as kinase inhibitors
|
US9526737B2
(en)
|
2007-12-03 |
2016-12-27 |
The Regents Of The University Of California |
Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and Wnt signaling
|
US8058259B2
(en)
*
|
2007-12-20 |
2011-11-15 |
University Of Virginia Patent Foundation |
Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
|
WO2009099650A2
(en)
*
|
2008-02-07 |
2009-08-13 |
Carson Dennis A |
Treatment of bladder diseases with a tlr7 activator
|
US8142764B2
(en)
|
2008-02-27 |
2012-03-27 |
University Of Louisville Research Foundation |
Synthetic biofilm-inhibiting peptides
|
WO2009114539A2
(en)
*
|
2008-03-10 |
2009-09-17 |
University Of Louisville Research Foundation |
Neuroprotective integrin-binding peptide and angiopoietin-1 treatments
|
WO2009114921A1
(en)
*
|
2008-03-17 |
2009-09-24 |
Dmitrienko Gary I |
INHIBITORS OF CLASS B AND CLASS D β-LACTAMASES
|
WO2009146112A1
(en)
*
|
2008-04-02 |
2009-12-03 |
University Of Virginia Patent Foundation |
Compositions and methods for inhibiting sphingosine kinase
|
EP2947097A1
(de)
|
2008-04-07 |
2015-11-25 |
Ablynx N.V. |
Gegen Notch-Signalwege gerichtete Aminosäuresequenzen und Verwendungen davon
|
US9212226B2
(en)
|
2008-05-16 |
2015-12-15 |
Ablynx N.V. |
Amino acid sequences directed against CXCR4 and other GPCRs and compounds comprising the same
|
US9872867B2
(en)
*
|
2008-06-06 |
2018-01-23 |
Tanya Kuritz |
Methods and compositions for modulation of innate immunity
|
EP2299809B1
(de)
|
2008-06-17 |
2018-10-17 |
Ben Gurion University Of The Negev R&D Authority |
Substituierte cyclohexyliden-ethyliden-octahydroinden-verbindungen
|
WO2010005534A2
(en)
*
|
2008-06-30 |
2010-01-14 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Proteasome inhibitors for selectively inducing apoptosis in cancer cells
|
US7947717B2
(en)
*
|
2008-07-18 |
2011-05-24 |
Burnham Institute For Medical Research |
Inhibitors of lethal factor protease
|
US9125821B2
(en)
|
2008-07-28 |
2015-09-08 |
The Regents Of The University Of California |
Nanodrug targeting protein geranylgeranylation
|
US20110178138A1
(en)
|
2008-07-28 |
2011-07-21 |
The Regents Of The University Of California |
Inhibitors of protein prenyltransferases
|
US9132168B2
(en)
|
2008-08-05 |
2015-09-15 |
University Of South Florida |
Methods of treating cognitive impairment
|
WO2010017224A2
(en)
*
|
2008-08-05 |
2010-02-11 |
University Of South Florida |
Methods of treating cognitive impairment
|
JP2011530539A
(ja)
*
|
2008-08-08 |
2011-12-22 |
ユニバーシティ オブ フロリダ リサーチ ファウンデーション,インク. |
腫瘍形成を抑制する脂質化合物
|
US9801865B2
(en)
*
|
2008-09-24 |
2017-10-31 |
The United States Of America As Represented By The Department Of Veteran Affairs |
Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation
|
US8124654B2
(en)
*
|
2008-11-11 |
2012-02-28 |
Immune Modulation, Inc. |
Derivatives of hypoestoxide and related compounds
|
TW201038578A
(en)
|
2009-01-30 |
2010-11-01 |
Univ Rutgers |
Methods to treat cancer
|
WO2010088924A1
(en)
|
2009-02-06 |
2010-08-12 |
Telormedix Sa |
Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
|
BRPI1008383A2
(pt)
|
2009-02-11 |
2016-02-23 |
Univ California |
composto, composição farmacêutica, método para prevenir, inibir ou tratar uma condição, e, uso de um composto
|
WO2010102219A1
(en)
|
2009-03-06 |
2010-09-10 |
Rutgers, The State University Of New Jersey |
Methylenedioxybenzo [i] phenanthridine derivatives used to treat cancer
|
WO2010108190A1
(en)
|
2009-03-20 |
2010-09-23 |
University Of Iowa Research Foundation |
Prenylated bisphosphonates as anti-tuberculosis agents
|
EP2417163B1
(de)
|
2009-04-10 |
2019-02-27 |
Ablynx N.V. |
Verbesserte, gegen il-6r gerichtete aminosauresequenzen und polypeptide, die diese enthalten, zur behandlung von erkrankungen und storungen, die mit il-6r in zusammenhang stehen
|
US8487131B2
(en)
|
2009-04-15 |
2013-07-16 |
Sanford-Burnham Medical Research Institute |
Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)
|
EA201101326A1
(ru)
|
2009-04-15 |
2012-05-30 |
Сэнфорд-Бёрнхэм Медикал Рисёч Инститьют |
Ингибиторы антиапоптотических белков на основе нафталина
|
US20120108823A1
(en)
|
2009-04-22 |
2012-05-03 |
The Ohio State University Research Foundation |
Anti-francisella agents
|
WO2010132504A1
(en)
|
2009-05-11 |
2010-11-18 |
University Of Tennessee Research Foundation |
Anti-inflammatory quinic acid derivatives for radioprotection/radiomitigation
|
WO2010132684A2
(en)
|
2009-05-13 |
2010-11-18 |
University Of Virginia Patent Foundation |
Inhibitors of inv(16) leukemia
|
KR20120107065A
(ko)
|
2009-06-30 |
2012-09-28 |
포레스트 래보러토리즈 홀딩스 리미티드 |
A2ar 효현제용 알콕시 카르보닐 아미노 알키닐 아데노신 화합물 및 그 유도체
|
WO2011005871A1
(en)
|
2009-07-07 |
2011-01-13 |
Pgxhealth, Llc |
Substituted 8-[6-carbonylamine-3-pyridyl]xanthines as adenosine a2b antagonists
|
WO2011004166A1
(en)
|
2009-07-09 |
2011-01-13 |
Cbt Development Limited |
Combined preparation for use as a medicament
|
AU2010278730A1
(en)
|
2009-07-31 |
2012-03-01 |
Biocryst Pharmaceuticals, Inc. |
Pyrrolo [1, 2-b] pyridazine derivatives as janus kinase inhibitors
|
US9040673B2
(en)
|
2009-08-14 |
2015-05-26 |
University Of Virginia Patent Foundation |
Synthesis and identification of novel RSK-specific inhibitors
|
TW201111385A
(en)
|
2009-08-27 |
2011-04-01 |
Biocryst Pharm Inc |
Heterocyclic compounds as janus kinase inhibitors
|
EP2473041B1
(de)
|
2009-09-04 |
2018-03-07 |
Merck Sharp & Dohme Corp. |
Modulatoren von zellzyklus-kontrollpunkten und ihre verwendung in kombination mit kontrollpunkt-kinasehemmern
|
US8642088B2
(en)
|
2009-09-04 |
2014-02-04 |
Wisconsin Alumni Research Foundation |
Tannin-chitosan composites
|
JP2013507380A
(ja)
*
|
2009-10-08 |
2013-03-04 |
サンフォード−バーンハム メディカル リサーチ インスティテュート |
抗癌剤としてのアポゴシポロン誘導体
|
CA2780145A1
(en)
|
2009-11-05 |
2011-05-12 |
Rutgers, The State University Of New Jersey |
Therapeutic compounds
|
KR20120092175A
(ko)
|
2009-12-04 |
2012-08-20 |
죤 이. 그랜트 |
카테콜-0-메틸-트랜스퍼라제 저해제를 사용한 충동 제어 장애의 치료
|
EP2516396A1
(de)
|
2009-12-23 |
2012-10-31 |
Wayne State University |
Therapeutische verbindungen
|
EP2516444A2
(de)
|
2009-12-23 |
2012-10-31 |
Biocryst Pharmaceuticals, Inc. |
Heterocyclische verbindungen als januskinasehemmer
|
WO2011103202A2
(en)
|
2010-02-16 |
2011-08-25 |
Aragon Pharmaceuticals, Inc. |
Androgen receptor modulators and uses thereof
|
CA2828114A1
(en)
|
2010-02-26 |
2011-09-01 |
Gary Igor DMITRIENKO |
Cephalosporin derivatives useful as .beta.-lactamase inhibitors and compositions and methods of use thereof
|
US8697105B2
(en)
|
2010-03-29 |
2014-04-15 |
Surmodics, Inc. |
Injectable drug delivery formulation
|
WO2011123856A1
(en)
|
2010-04-02 |
2011-10-06 |
Tsrl, Inc. |
Neuraminidase inhibitors
|
WO2011127344A2
(en)
|
2010-04-08 |
2011-10-13 |
University Of Virginia Patent Foundation |
Method to detect and treat infectious or inflammatory diarrhea
|
US9221808B2
(en)
|
2010-04-16 |
2015-12-29 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinase (ROCK) and methods of use
|
WO2011133696A2
(en)
|
2010-04-20 |
2011-10-27 |
Regents Of The University Of Minnesota |
Methods of suppressing atherosclerosis
|
WO2011150356A1
(en)
|
2010-05-28 |
2011-12-01 |
Biocryst Pharmaceuticals, Inc. |
Heterocyclic compounds as janus kinase inhibitors
|
WO2011156626A1
(en)
|
2010-06-09 |
2011-12-15 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
US9102617B2
(en)
|
2010-06-25 |
2015-08-11 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
US8741317B2
(en)
|
2010-08-19 |
2014-06-03 |
Rutgers, The State University Of New Jersey |
Slow-degrading polymers comprising salicylic acid for undelayed and sustained drug delivery
|
WO2012027494A1
(en)
|
2010-08-24 |
2012-03-01 |
Regents Of The University Of Minnesota |
Bispecific targeting reagents
|
WO2012038058A1
(en)
|
2010-09-21 |
2012-03-29 |
Telormedix Sa |
Treatment of conditions by toll-like receptor modulators
|
MX2013004679A
(es)
|
2010-10-25 |
2014-02-20 |
Univ Minnesota |
Composicion terapeutica para el tratamiento de glioblastoma.
|
WO2012058665A1
(en)
|
2010-10-29 |
2012-05-03 |
University Of Connecticut |
Compositions and methods for modulation and detection of immune and inflammatory responses
|
EP2635274B1
(de)
|
2010-11-01 |
2017-12-06 |
The Ohio State University Research Foundation |
Celecoxibderivate gegen staphylokokken
|
WO2012065051A1
(en)
|
2010-11-12 |
2012-05-18 |
Enzon Pharmaceuticals, Inc. |
Compositions and methods for treating androgen receptor dependent disorders including cancers
|
WO2012074960A2
(en)
|
2010-11-29 |
2012-06-07 |
The Ohio State University Research Foundation |
Fty720-derived anticancer agents
|
WO2012087889A2
(en)
|
2010-12-20 |
2012-06-28 |
The Ohio State University Research Foundation |
Dna methylation inhibitors
|
US8933119B2
(en)
|
2011-01-03 |
2015-01-13 |
The William M. Yarbrough Foundation |
Method for treating phytophotodermatitis
|
US10647668B2
(en)
|
2011-01-03 |
2020-05-12 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactant and associated method of use
|
US9962361B2
(en)
|
2011-01-03 |
2018-05-08 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
|
US11407713B2
(en)
|
2011-01-03 |
2022-08-09 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
|
US10640464B2
(en)
|
2011-01-03 |
2020-05-05 |
The William M. Yarbrough Foundation |
Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
|
US11279674B2
(en)
|
2011-01-03 |
2022-03-22 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactant and associated method of use
|
US10308599B2
(en)
|
2011-01-03 |
2019-06-04 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
|
US10273205B2
(en)
|
2011-01-03 |
2019-04-30 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
|
US8865765B2
(en)
|
2011-01-12 |
2014-10-21 |
The William M. Yarbrough Foundation |
Method for treating eczema
|
ME02556B
(de)
|
2011-02-07 |
2017-02-20 |
Biogen Ma Inc |
S1p-modulierende mittel
|
US9532969B2
(en)
|
2011-02-08 |
2017-01-03 |
The William M. Yarbrough Foundation |
Method for treating psoriasis
|
CA2865487A1
(en)
|
2011-03-07 |
2012-09-13 |
Paula J. Bates |
Predictive marker of dnmt1 inhibitor therapeutic efficacy and methods of using the marker
|
WO2012135697A2
(en)
|
2011-03-30 |
2012-10-04 |
H. Lee Moffitt Cancer Center & Research Institute Inc. |
Novel rho kinase inhibitors and methods of use
|
MX356426B
(es)
|
2011-04-04 |
2018-05-29 |
Univ Iowa Res Found |
Metodos para mejorar inmunogenicidad de vacuna.
|
US20140030341A1
(en)
|
2011-04-06 |
2014-01-30 |
Rutgers, The State University Of New Jersey |
Polymers and methods for the treatment of pain
|
JP5978291B2
(ja)
|
2011-04-19 |
2016-08-24 |
アルファーマ インコーポレイテッドAlfama,Inc. |
一酸化炭素放出分子およびその使用
|
WO2012145678A1
(en)
|
2011-04-20 |
2012-10-26 |
Regents Of The University Of Minnesota |
Anti-cancer and anti-inflammatory parthenolide compounds
|
WO2012177770A1
(en)
|
2011-06-20 |
2012-12-27 |
Rutgers, The State University Of New Jersey |
Bipartite inhibitors of bacterial rna polymerase
|
US9133230B2
(en)
|
2011-06-21 |
2015-09-15 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Hydrazone derivatives having potent antitumor activity toward multi-drug resistant tumor cells
|
US9394338B2
(en)
|
2011-07-08 |
2016-07-19 |
Regents Of The University Of Minnesota |
Glutathione analogs and uses thereof
|
ES2628634T3
(es)
|
2011-07-21 |
2017-08-03 |
Alfama, Inc. |
Moléculas liberadoras de monóxido de carbono-rutenio y usos de las mismas
|
WO2013016206A1
(en)
|
2011-07-22 |
2013-01-31 |
University Of Louisville Research Foundation, Inc. |
Anti-biofilm compounds
|
EA028452B1
(ru)
|
2011-07-29 |
2017-11-30 |
Медивейшн Простейт Терапьютикс, Инк. |
Лечение рака молочной железы
|
US20150017091A1
(en)
|
2011-08-18 |
2015-01-15 |
Cornell University |
Detection and treatment of metastatic disease
|
WO2013028866A1
(en)
|
2011-08-24 |
2013-02-28 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
CA2846860A1
(en)
|
2011-08-30 |
2013-03-07 |
Wayne State University |
Therapeutic compounds and methods
|
WO2013033345A1
(en)
|
2011-08-30 |
2013-03-07 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
WO2013036931A1
(en)
|
2011-09-08 |
2013-03-14 |
Western University Of Health Sciences |
Targeted liposomes in cancer therapy
|
EP2910549A1
(de)
|
2011-09-15 |
2015-08-26 |
Arizona Board of Regents, a Body Corporate of the State of Arizona acting for and on behalf of Arizona State University |
1,2,3,4-tetrahydro-1,1,4,4-tetramethylnaphthalenderivate als rxr-modulatoren zur behandlung von alzheimer-krankheit und krebs
|
TR201818978T4
(tr)
*
|
2011-11-04 |
2019-01-21 |
Enceladus Pharmaceuticals B V |
İnsanlardaki İnflamatuvar Rahatsızlıkların Tedavisine Yönelik Lipozomal Kortikosteroidler
|
US9828326B2
(en)
*
|
2011-12-27 |
2017-11-28 |
Northeast Ohio Medical University |
Amooranin compounds and analogs thereof and related methods of use
|
US9517994B2
(en)
|
2012-01-05 |
2016-12-13 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: phloroglucinol derivatives
|
WO2013106572A1
(en)
|
2012-01-11 |
2013-07-18 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University |
Bispecific antibody fragments for neurological disease proteins and methods of use
|
US9822108B2
(en)
|
2012-01-13 |
2017-11-21 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
EP2804606B1
(de)
|
2012-01-19 |
2017-06-28 |
Hybrid Medical, LLC |
Topische therapeutische formulierungen
|
WO2013109972A2
(en)
|
2012-01-20 |
2013-07-25 |
Regents Of The University Of Minnesota |
Therapeutic compounds
|
US9488664B2
(en)
|
2012-01-25 |
2016-11-08 |
Sbi Pharmaceuticals Co., Ltd. |
Diagnostic agent for tumor
|
US20130195752A1
(en)
|
2012-02-01 |
2013-08-01 |
Regents Of The University Of Minnesota |
Functionalized nanoparticles and methods of use thereof
|
WO2013113102A1
(en)
|
2012-02-01 |
2013-08-08 |
The Governors Of The University Of Alberta |
USE OF PDGFR-α AS DIAGNOSTIC MARKER FOR PAPILLARY THYROID CANCER
|
WO2013119564A1
(en)
|
2012-02-06 |
2013-08-15 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: combination of a rifamycin and a switch region inhibitor
|
US9688668B2
(en)
|
2012-02-08 |
2017-06-27 |
University Of Virginia Patent Foundation |
Long chain base sphingosine kinase inhibitors
|
US9592229B2
(en)
|
2012-03-02 |
2017-03-14 |
The Board Of Trustees Of The University Of Illinois |
Potent anticancer activity via dual compound activation
|
DK2822546T3
(en)
|
2012-03-06 |
2017-10-30 |
The Board Of Trustees Of The Univ Of Illionis |
PROCASPACE COMBINATION THERAPY FOR CANCER TREATMENT
|
US9475783B2
(en)
|
2012-03-21 |
2016-10-25 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
WO2013142812A1
(en)
|
2012-03-22 |
2013-09-26 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: sidechain-fluorinated myxopyronin derivatives
|
CN104583203B
(zh)
|
2012-03-26 |
2017-06-13 |
衣阿华大学研究基金会 |
Schweinfurthin类似物
|
US9272016B2
(en)
|
2012-04-20 |
2016-03-01 |
University Of Iowa Research Foundation |
Methods to enhance RNAi oligonucleotide delivery to respiratory epithelial cells
|
JP6262723B2
(ja)
|
2012-05-07 |
2018-01-17 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California |
オキシステロールアナログoxy133は、骨発生及びヘッジホッグシグナル伝達を誘導し、脂肪生成を阻害する
|
EP2852390A1
(de)
|
2012-05-21 |
2015-04-01 |
Chemi Nutra Inc. |
Zusammensetzungen und verfahren zur erhöhung der festigkeit und muskelmasse
|
WO2013177458A1
(en)
|
2012-05-23 |
2013-11-28 |
Chemi Nutra |
Compositions for increasing strength, muscle mass, and lean body mass
|
EP2854834A4
(de)
|
2012-05-30 |
2016-05-18 |
Biostrategies LC |
Pflanzenlektine als träger entsprechender wirkstoffe in tierischen und menschlichen zellen
|
US9434681B2
(en)
|
2012-06-15 |
2016-09-06 |
Rutgers, The State University Of New Jersey |
Macromolecules for treating atherosclerosis
|
JP6240180B2
(ja)
|
2012-06-18 |
2017-11-29 |
ダート・ニューロサイエンス・(ケイマン)・リミテッド |
置換チオフェン−およびフラン−縮合アゾロピリミジン−5−(6h)−オン化合物
|
EP2861570B1
(de)
|
2012-06-19 |
2018-07-18 |
Rutgers, The State University of New Jersey |
Antibakterielle wirkstoffe: arylmyxopyroninderivate
|
EP2863910B1
(de)
|
2012-06-20 |
2020-03-11 |
University Of Virginia Patent Foundation |
Zusammensetzungen und verfahren zur regulierung einer glucosehomöostase und einer insulinwirkung
|
JP6226974B2
(ja)
|
2012-07-05 |
2017-11-08 |
ユニバーシティー オブ アイオワ リサーチ ファウンデーション |
治療用ビスホスホネート
|
EP2872525B1
(de)
|
2012-07-10 |
2019-03-06 |
XPD Holdings LLC |
Stabilisierte multifunktionale antioxidative verbindungen und verfahren zur verwendung
|
BR112015001201B1
(pt)
|
2012-07-18 |
2022-02-22 |
University Of Notre Dame Du Lac |
Compostos anti-infecciosos 5,5-heteroaromáticos e composição
|
WO2014018671A1
(en)
|
2012-07-24 |
2014-01-30 |
Regents Of The University Of Minnesota |
Therapeutic compounds for the treatment of cancer
|
US10441561B2
(en)
|
2012-07-26 |
2019-10-15 |
The William M. Yanbrough Foundation |
Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
|
US9949943B2
(en)
|
2012-07-26 |
2018-04-24 |
The William M. Yarbrough Foundation |
Method for treating neurodegenerative diseases
|
US10434082B2
(en)
|
2012-07-26 |
2019-10-08 |
The William M. Yarbrough Foundation |
Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
|
US10434081B2
(en)
|
2012-07-26 |
2019-10-08 |
The William M. Yarbrough Foundation |
Inhibitors of macrophage migration inhibitory factor
|
WO2014018874A1
(en)
|
2012-07-26 |
2014-01-30 |
The William M. Yarbrough Foundation |
Method for treating skin cancer
|
US10080734B2
(en)
|
2012-07-26 |
2018-09-25 |
The William M. Yarbrough Foundation |
Method for treating autism and other neurodevelopmental disorders
|
US10335387B2
(en)
|
2012-07-26 |
2019-07-02 |
The William M. Yarbrough Foundation |
Method for treating infectious diseases with isothiocyanate functional compounds
|
US9839621B2
(en)
|
2012-07-26 |
2017-12-12 |
The William M. Yarbrough Foundation |
Method for treating bladder cancer
|
MX363388B
(es)
|
2012-07-27 |
2019-03-20 |
Biogen Ma Inc |
Agentes moduladores de autotaxina.
|
JP6545618B2
(ja)
|
2012-08-01 |
2019-07-17 |
ルイス アンド クラーク ファーマスーティカルズ,インコーポレイテッドLewis and Clark Pharmaceuticals,Inc. |
A2aアゴニストとしてのn−アルキル2−(二置換)アルキニルアデノシン−5’−ウロンアミド
|
RU2652989C2
(ru)
|
2012-08-03 |
2018-05-04 |
Зэ Борд оф Трастиз оф зэ Юниверсити оф Иллинойс |
Соединения и композиции, активирующие ферменты
|
EP2879674B1
(de)
|
2012-08-06 |
2017-11-22 |
Biogen MA Inc. |
Verbindungen als s1p-modulierende mittel und/oder atx-modulierende mittel
|
US9499485B2
(en)
|
2012-08-06 |
2016-11-22 |
Biogen Ma Inc. |
Compounds that are S1P modulating agents and/or ATX modulating agents
|
WO2014028025A1
(en)
|
2012-08-16 |
2014-02-20 |
University Of Southern California |
Compositions and methods for treating myotonic dystrophy type 1
|
US10208043B2
(en)
|
2012-08-22 |
2019-02-19 |
Cornell University |
Methods for inhibiting fascin
|
US9737493B2
(en)
|
2012-09-07 |
2017-08-22 |
University Of Louisville Research Foundation, Inc. |
Compositions and methods for modulating DNMT1 inhibitor activity
|
US9573938B2
(en)
|
2012-09-11 |
2017-02-21 |
Rutgers, The State University Of New Jersey |
Therapeutic hydroxypyridinones, hydroxypyrimidinones and hydroxypyridazinones
|
WO2014041546A1
(en)
|
2012-09-13 |
2014-03-20 |
Ben-Gurion University Of The Negev Research And Development Authority |
Diagnostic agents with enhanced sensitivity/specificity
|
WO2014043510A1
(en)
|
2012-09-13 |
2014-03-20 |
Chang Gung Memorial Hospital |
A novel pharmaceutical composition and uses thereof
|
KR20220025231A
(ko)
|
2012-09-26 |
2022-03-03 |
아라곤 파마슈티컬스, 인코포레이티드 |
비전이성 거세 저항성 전립선암 치료용 항안드로겐
|
EP2906260B1
(de)
|
2012-10-09 |
2019-06-26 |
Case Western Reserve University |
Stabförmige pflanzenvirusnanopartikel als kontrastmittelplattformen
|
AU2013329171A1
(en)
|
2012-10-10 |
2015-04-30 |
Arizona Board Of Regents, On Behalf Of Arizona State University |
Multifunctional radical quenchers
|
US20140120057A1
(en)
|
2012-10-25 |
2014-05-01 |
Rutgers, The State University Of New Jersey |
Polymers and methods thereof for wound healing
|
WO2014066840A1
(en)
|
2012-10-26 |
2014-05-01 |
Regents Of The University Of Minnesota |
Aurora kinase inhibitors
|
WO2014070774A1
(en)
|
2012-10-29 |
2014-05-08 |
Southern Methodist University |
Methods of generating beta-lactamase resistant carbapenem compounds
|
WO2014074932A1
(en)
|
2012-11-08 |
2014-05-15 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
US9701638B2
(en)
|
2012-11-09 |
2017-07-11 |
Rutgers, The State University Of New Jersey |
Therapeutic hydroxyquinolones
|
CA2890905A1
(en)
|
2012-11-16 |
2014-05-22 |
Biocryst Pharmaceuticals, Inc. |
Antiviral azasugar-containing nucleosides
|
WO2014078857A1
(en)
|
2012-11-19 |
2014-05-22 |
Regents Of The University Of Minnesota |
Ergoline derivatives as dopamine receptor modulators
|
ES2749467T3
(es)
|
2012-11-20 |
2020-03-20 |
Biogen Ma Inc |
Agentes moduladores de S1p y/o ATX
|
WO2014081752A1
(en)
|
2012-11-20 |
2014-05-30 |
Biogen Idec Ma Inc. |
S1p and/or atx modulating agents
|
US9522131B2
(en)
|
2013-01-11 |
2016-12-20 |
Wisconsin Alumni Research Foundation |
Tannin-containing gastrointestinal formulations and methods of use
|
JOP20200097A1
(ar)
|
2013-01-15 |
2017-06-16 |
Aragon Pharmaceuticals Inc |
معدل مستقبل أندروجين واستخداماته
|
JP6434425B2
(ja)
|
2013-01-29 |
2018-12-05 |
バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. |
S1p調節剤
|
WO2014124317A1
(en)
|
2013-02-08 |
2014-08-14 |
Regents Of The University Of Minnesota |
Analgesic conjugates
|
KR20150119188A
(ko)
|
2013-02-15 |
2015-10-23 |
리젠츠 오브 더 유니버시티 오브 미네소타 |
입자 기능화
|
EP2964618B1
(de)
|
2013-03-05 |
2019-09-04 |
University Of Notre Dame Du Lac |
Chinazolinon-antibiotika
|
JP6346658B2
(ja)
|
2013-03-14 |
2018-06-20 |
ダート・ニューロサイエンス・(ケイマン)・リミテッド |
Mao阻害剤としての置換ナフチリジン及びキノリン化合物
|
RU2668073C2
(ru)
|
2013-03-14 |
2018-09-26 |
Дарт Нейросайенс (Кайман) Лтд. |
Замещенные пиридиновые и пиразиновые соединения в качестве ингибиторов pde4
|
US9617282B2
(en)
|
2013-03-15 |
2017-04-11 |
Biogen Ma Inc. |
Macrocyclic compounds as IRAK4 inhibitors for the treatment of inflammatory diseases
|
BR112015023184A2
(pt)
|
2013-03-15 |
2017-11-21 |
Constellation Pharmaceuticals Inc |
método para o tratamento de uma doença, inibidor e seu uso, composição, método de identificação de um composto e método para inibir a produção de il-4, il-5 e il-13
|
CN110483413B
(zh)
|
2013-03-15 |
2023-02-28 |
百缮药业(苏州)有限公司 |
用于制备碳环糖衍生物的方法
|
US9387250B2
(en)
|
2013-03-15 |
2016-07-12 |
Rutgers, The State University Of New Jersey |
Therapeutic compositions for bone repair
|
TW201446768A
(zh)
|
2013-03-15 |
2014-12-16 |
Biogen Idec Inc |
S1p及/或atx調節劑
|
AU2014259672A1
(en)
|
2013-05-02 |
2015-12-03 |
The Regents Of The University Of California |
Bone-selective osteogenic oxysterol-bone targeting agents
|
CN105555363B
(zh)
|
2013-05-06 |
2019-03-12 |
长庚医疗财团法人高雄长庚纪念医院 |
医药组成物及其用途
|
WO2014194055A1
(en)
|
2013-05-29 |
2014-12-04 |
Rutgers, The State University Of New Jersey |
Antioxidant-based poly(anhydride-esters)
|
US9452217B2
(en)
|
2013-06-22 |
2016-09-27 |
Nitor Therapeutics |
Methods for potentiating immune response for the treatment of infectious diseases and cancer
|
US10682415B2
(en)
|
2013-07-22 |
2020-06-16 |
Wisconsin Alumni Research Foundation |
Thermogel formulation for combination drug delivery
|
WO2015017715A1
(en)
|
2013-08-01 |
2015-02-05 |
Regents Of The University Of Minnesota |
Drug delivery method
|
CN104341504B
(zh)
|
2013-08-06 |
2017-10-24 |
百奥泰生物科技(广州)有限公司 |
双特异性抗体
|
WO2015021149A1
(en)
|
2013-08-06 |
2015-02-12 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibitors of ack1/tnk2 tyrosine kinase
|
WO2015038966A1
(en)
|
2013-09-12 |
2015-03-19 |
Regents Of The University Of Minnesota |
Semi-solid delivery systems
|
US9878045B2
(en)
|
2013-10-15 |
2018-01-30 |
Regents Of The University Of Minnesota |
Triorthogonal reagents for dual protein conjugation
|
EP3068416A4
(de)
|
2013-11-11 |
2017-08-09 |
Kuality Herbceutics LLC |
Therapeutische verbindungen aus kava und verfahren zur verwendung davon
|
US9387199B2
(en)
|
2013-11-12 |
2016-07-12 |
University Of Virginia Patent Foundation |
Compositions and methods for treating clostridium infection and preventing recurrence of infection
|
US9339482B2
(en)
|
2013-11-22 |
2016-05-17 |
Regents Of The University Of Minnesota |
Methods to treat dysregulated blood glucose disorders
|
US9315523B2
(en)
|
2013-12-06 |
2016-04-19 |
Rutgers, The State University Of New Jersey |
Cyclic dinucleosides
|
US10328040B2
(en)
|
2014-01-17 |
2019-06-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic methods
|
US9919998B2
(en)
|
2014-02-06 |
2018-03-20 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: Nα-aroyl-N-aryl-phenylalaninamides
|
US20150231077A1
(en)
|
2014-02-17 |
2015-08-20 |
The Cleveland Clinic Foundation |
Amine passivated nanoparticles for cancer treatment and imaging
|
DK3107902T3
(da)
|
2014-02-20 |
2021-05-03 |
Cornell Univ Cornell Center For Technology Enterprise & Commercialization Cctec |
Forbindelser og fremgangsmåder til at hæmme fascin
|
US10189874B2
(en)
|
2014-02-26 |
2019-01-29 |
Arizona Board Of Regents On Behalf Of Arizona State University |
DNA gridiron compositions and methods
|
WO2015130973A1
(en)
|
2014-02-26 |
2015-09-03 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
US10272055B2
(en)
|
2014-03-06 |
2019-04-30 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
BR112016020199A8
(pt)
|
2014-03-07 |
2021-07-20 |
Biocryst Pharm Inc |
composto inibidor de calicreína plasmática de humano, composição farmacêutica compreendendo o referido composto, kit e seu uso
|
WO2015153560A1
(en)
|
2014-03-31 |
2015-10-08 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Stabilized peptoid-peptide hybrids and uses thereof
|
WO2015166355A2
(en)
|
2014-04-18 |
2015-11-05 |
The Governors Of The University Of Alberta |
Targeted therapy to restore radioactive iodine transport in thyroid cancer
|
ES2759246T3
(es)
|
2014-04-23 |
2020-05-08 |
Dart Neuroscience Cayman Ltd |
Compuestos de[1,2,4]triazolo[1,5-a]pirimidinilo-7-il sustituidos como inhibidores de PDE2
|
EP3134406A1
(de)
|
2014-04-24 |
2017-03-01 |
Dart Neuroscience (Cayman) Ltd |
Substituierte 2,4,5,6-tetrahydropyrrolo [ 3,4-c ] pyrazol-und 4,5,6,7-tetrahydro-2 h-pyrazolo [ 4,3-c ] pyridinverbindungen als glyt1-inhibitoren
|
US9556113B2
(en)
|
2014-04-29 |
2017-01-31 |
The South Dakota Board Of Regents |
Combination uses of dichloroacetate and oxamate, and their prodrugs, for cancer treatment
|
US9987299B2
(en)
|
2014-05-05 |
2018-06-05 |
University Of Iowa Research Foundation |
Methods of improving RNAi in well-differentiated airway epithelia
|
WO2015188051A1
(en)
|
2014-06-06 |
2015-12-10 |
Biogen Ma Inc. |
Atx modulating agents
|
WO2015191742A1
(en)
|
2014-06-13 |
2015-12-17 |
Rutgers, The State University Of New Jersey |
Process and intermediates for preparing poly(anhydride-esters)
|
WO2015195563A1
(en)
|
2014-06-16 |
2015-12-23 |
Rutgers, The State University Of New Jersey |
Antibacterial agents
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
US9737598B2
(en)
|
2014-06-30 |
2017-08-22 |
Regents Of The University Of Minnesota |
CD200 inhibitors and methods of use thereof
|
US20170191041A1
(en)
|
2014-07-11 |
2017-07-06 |
Biostrategies LC |
Materials and methods for treating disorders associated with sulfatase enzymes
|
US10246456B2
(en)
|
2014-07-18 |
2019-04-02 |
Biogen Ma Inc. |
IRAK4 inhibiting agents
|
EP3232199B1
(de)
*
|
2014-08-19 |
2022-05-04 |
National University Corporation Okayama University |
Verfahren zur erhöhung der immunzellenfunktion und verfahren zur beurteilung der multifunktionalität von immunzellen
|
WO2016027262A1
(en)
|
2014-08-19 |
2016-02-25 |
Miller Marvin J |
Antibacterial sideromycins
|
WO2016037171A1
(en)
|
2014-09-05 |
2016-03-10 |
The Cleveland Clinic Foundation |
Flavonoid il-17a inhibitors
|
US9630905B2
(en)
|
2014-09-08 |
2017-04-25 |
Rutgers, The State University Of New Jersey |
Amphiphilic macromolecules and methods of use thereof
|
EP3191086B1
(de)
|
2014-09-11 |
2021-05-05 |
University of Iowa Research Foundation |
Thymol und carvacol zur verwendung in der medizin
|
US10328114B2
(en)
|
2014-10-28 |
2019-06-25 |
University Of Iowa Research Foundation |
Lung injury repair compositions and methods
|
US10239882B2
(en)
|
2014-11-05 |
2019-03-26 |
Dart Neuroscience (Cayman) Ltd. |
Substituted 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine compounds as PDE2 inhibitors
|
US10040759B2
(en)
|
2014-11-05 |
2018-08-07 |
Dart Neuroscience (Cayman) Ltd. |
Substituted azetidinyl compounds as GlyT1 inhibitors
|
KR20170081261A
(ko)
*
|
2014-11-10 |
2017-07-11 |
델 마 파마슈티컬스 인코포레이티드 |
방사선과 함께 폐의 비-소세포 암종 및 다형성 교아종을 치료하기 위한 디안하이드로갈락티톨
|
US10920195B2
(en)
|
2014-11-13 |
2021-02-16 |
University Of Iowa Research Foundation |
Methods to generate epithelial cells
|
EP3229810B1
(de)
|
2014-11-17 |
2020-07-22 |
Cellectar Biosciences, Inc. |
Phospholipidetheranaloga als auf krebs abzielende arzneimittelträger
|
US11426468B2
(en)
|
2014-12-19 |
2022-08-30 |
Ablynx N.V. |
Cysteine linked nanobody dimers
|
US20180000736A1
(en)
|
2015-01-08 |
2018-01-04 |
University Of Iowa Research Foundation |
Methods for the regeneration of articular cartilage in vivo
|
WO2016115516A1
(en)
|
2015-01-16 |
2016-07-21 |
University Of Iowa Research Foundation |
Methods to prevent or treat periodontitis or peri-implantitis
|
EP3258938B1
(de)
|
2015-02-17 |
2020-12-02 |
Arizona Board of Regents on behalf of Arizona State University |
Phenothiazinanaloge als mitochondriales therapeutisches mittel
|
US10364227B2
(en)
|
2015-02-17 |
2019-07-30 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
WO2016140978A1
(en)
|
2015-03-03 |
2016-09-09 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
WO2016140979A1
(en)
|
2015-03-03 |
2016-09-09 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
JP2018507246A
(ja)
|
2015-03-06 |
2018-03-15 |
ザ クリーヴランド クリニック ファウンデーションThe Cleveland Clinic Foundation |
ステロイド依存性疾患を治療するためのステロイド代謝の改変
|
US9926261B2
(en)
|
2015-03-10 |
2018-03-27 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
US9950993B2
(en)
|
2015-03-13 |
2018-04-24 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
WO2016164898A1
(en)
|
2015-04-10 |
2016-10-13 |
Rutgers, The State University Of New Jersey |
Kojic acid polymers
|
AU2016258123A1
(en)
|
2015-05-06 |
2018-01-04 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Radiotherapeutic and companion imaging agents to target MC1R
|
US10584108B2
(en)
|
2015-05-07 |
2020-03-10 |
Kuality Herbceutics Llc |
Therapeutic compounds and methods of use thereof
|
US20180125780A1
(en)
|
2015-05-15 |
2018-05-10 |
The Methodist Hospital System |
Implantable nanochannel delivery devices
|
EP3297655B1
(de)
|
2015-05-18 |
2020-04-15 |
Arizona Board of Regents on Behalf of the University of Arizona |
Verbesserte melanomkrebsprävention durch neuartige melanotropine
|
CN117257802A
(zh)
|
2015-06-05 |
2023-12-22 |
伊利诺伊大学董事会 |
Pac-1联合疗法
|
TW201710503A
(zh)
|
2015-06-12 |
2017-03-16 |
長庚醫療財團法人林口長庚紀念醫院 |
新穎多核苷酸、載體、醫藥組成物以及其用途
|
US11369569B2
(en)
|
2015-06-15 |
2022-06-28 |
University Of Virginia Patent Foundation |
Target-specific delivery of therapeutic agents
|
US10308663B2
(en)
|
2015-06-16 |
2019-06-04 |
University Of Virginia Patent Foundation |
Inhibitors of PTP4A3 for the treatment of cancer
|
US9399039B1
(en)
|
2015-06-30 |
2016-07-26 |
University Of South Florida |
Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use
|
US10814006B2
(en)
|
2015-07-14 |
2020-10-27 |
University Of Iowa Research Foundation |
Fluorescent prodrugs
|
WO2017011826A1
(en)
|
2015-07-16 |
2017-01-19 |
Case Western Reserve University |
Plant virus particles for delivery of antimitotic agents
|
AU2016298175B2
(en)
|
2015-07-28 |
2022-01-06 |
University Of Iowa Research Foundation |
Compositions and methods of treating cancer
|
AU2016301212A1
(en)
|
2015-08-02 |
2018-03-29 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibitors of ACK1/TNK2 tyrosine kinase
|
WO2017027883A1
(en)
|
2015-08-13 |
2017-02-16 |
San Diego State University Research Foundation |
Atropisomerism for increased kinase inhibitor selectivity
|
DK3344614T5
(da)
|
2015-09-04 |
2021-08-30 |
Janssen Pharmaceutica Nv |
Terapeutiske forbindelser til smerte og syntese deraf
|
EP3355890B1
(de)
|
2015-10-01 |
2021-11-10 |
Biocryst Pharmaceuticals, Inc. |
Menschliche plasmakallikreinhemmer
|
WO2017066428A1
(en)
|
2015-10-13 |
2017-04-20 |
H. Lee Moffitt Cancer Center & Research Institute, Inc. |
Brd4-kinase inhibitors as cancer therapeutics
|
EP3365018A1
(de)
|
2015-10-20 |
2018-08-29 |
The Cleveland Clinic Foundation |
Stimulierung von 11beta-hsd2-expression zur verbesserung der hormontherapie einer steroidabhängigen erkrankung
|
JP6902185B2
(ja)
|
2015-11-03 |
2021-07-14 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
Cd200阻害剤及びその使用方法
|
CN108601789A
(zh)
|
2015-11-20 |
2018-09-28 |
生华生物科技股份有限公司 |
用于治疗癌症的四环喹诺酮类似物组合疗法
|
US9957282B2
(en)
|
2015-12-14 |
2018-05-01 |
Senhwa Biosciences, Inc. |
Crystalline forms of quinolone analogs and their salts
|
US9980951B2
(en)
|
2015-12-17 |
2018-05-29 |
University Of Iowa Research Foundation |
Image guided therapy for cancer
|
TWI726969B
(zh)
|
2016-01-11 |
2021-05-11 |
比利時商健生藥品公司 |
用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
|
US11427561B2
(en)
|
2016-01-20 |
2022-08-30 |
Biogen Ma Inc. |
IRAK4 inhibiting agents
|
TW202222786A
(zh)
|
2016-02-01 |
2022-06-16 |
美商百歐克斯製藥公司 |
苯并吡唑化合物及其類似物
|
WO2017156527A1
(en)
|
2016-03-11 |
2017-09-14 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Aurora kinase and janus kinase inhibitors for prevention of graft versus host disease
|
MX2018011216A
(es)
|
2016-03-16 |
2019-08-29 |
H Lee Moffitt Cancer Ct & Res |
Moléculas pequeñas contra cereblon para mejorar la función efectora de los linfocitos t.
|
WO2017165558A1
(en)
|
2016-03-22 |
2017-09-28 |
Regents Of The University Of Minnesota |
Combination for treating pain
|
US10759740B2
(en)
|
2016-03-24 |
2020-09-01 |
Rutgers, The State University Of New Jersey |
Antibacterial agents
|
JP2019515025A
(ja)
|
2016-04-04 |
2019-06-06 |
ラトガース ザ ステイト ユニバーシティー オブ ニュージャージー |
トポイソメラーゼ毒
|
US10551384B2
(en)
|
2016-04-07 |
2020-02-04 |
Rutgers, The State University Of New Jersey |
MTOR kinase mutations and methods of use thereof
|
EP4230713A1
(de)
|
2016-04-18 |
2023-08-23 |
Gene Pool Technologies, Inc. |
Isolierung von pflanzenextrakten
|
AU2017260460A1
(en)
|
2016-05-04 |
2018-12-13 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
A delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer
|
US11697851B2
(en)
|
2016-05-24 |
2023-07-11 |
The Regents Of The University Of California |
Early ovarian cancer detection diagnostic test based on mRNA isoforms
|
KR102434879B1
(ko)
|
2016-05-26 |
2022-08-22 |
유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 |
폐혈관 질환 치료용 조성물 및 방법
|
US10899793B2
(en)
|
2016-05-27 |
2021-01-26 |
Regents Of The University Of Minnesota |
Melanocortin ligands and methods of use thereof
|
US11351270B2
(en)
|
2016-06-07 |
2022-06-07 |
University Of Iowa Research Foundation |
Junctophilin-2 fragments and uses therefor
|
KR20190026771A
(ko)
|
2016-06-20 |
2019-03-13 |
럿거스, 더 스테이트 유니버시티 오브 뉴 저지 |
치료 화합물
|
US11179484B2
(en)
|
2016-06-24 |
2021-11-23 |
University Of Iowa Research Foundation |
Compositions and methods of treating melanoma
|
ES2937307T3
(es)
|
2016-07-26 |
2023-03-27 |
Univ Southern California |
Inhibición selectiva del bromodominio del BDF1 fúngico
|
US20180037909A1
(en)
|
2016-08-04 |
2018-02-08 |
Chang Gung Memorial Hospital, Linkou |
Modified cancer cell lines and uses thereof
|
WO2018039077A1
(en)
|
2016-08-25 |
2018-03-01 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
KR102471059B1
(ko)
|
2016-08-31 |
2022-11-25 |
다트 뉴로사이언스, 엘엘씨 |
장애의 치료를 위한 하이드록시노르케타민 유도체
|
RU2019114964A
(ru)
|
2016-10-17 |
2020-11-17 |
Дженентек, Инк. |
Терапевтические средства и способы их применения
|
US11124541B2
(en)
|
2016-10-18 |
2021-09-21 |
Regents Of The University Of Minnesota |
Chimeric melanocortin ligands and methods of use thereof
|
JP7128181B2
(ja)
|
2016-10-31 |
2022-08-30 |
バイオクリスト ファーマスーティカルズ,インコーポレイテッド |
カリクレイン阻害剤のプロドラッグ
|
US11071747B2
(en)
|
2016-11-29 |
2021-07-27 |
University Of Iowa Research Foundation |
Use of NAD precursors for breast enhancement
|
CA3044814A1
(en)
|
2016-11-29 |
2018-06-07 |
Charles M. Brenner |
Use of nad precursors for improving maternal health and/or offspring health
|
US20180194824A1
(en)
|
2016-12-14 |
2018-07-12 |
University Of Iowa Research Foundation |
Musclin peptides and methods of use thereof
|
AR110590A1
(es)
|
2016-12-27 |
2019-04-10 |
Biogen Ma Inc |
Activador de nrf2
|
CN110337437B
(zh)
|
2016-12-28 |
2023-02-03 |
达特神经科学有限公司 |
作为pde2抑制剂的取代的吡唑并嘧啶酮化合物
|
US10710957B2
(en)
|
2017-01-09 |
2020-07-14 |
University Of Central Florida Research Foundation, Inc. |
Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria
|
US20180230105A1
(en)
|
2017-01-13 |
2018-08-16 |
Regents Of The University Of Minnesota |
Therapeutic compounds
|
CN110325508B
(zh)
|
2017-01-20 |
2023-06-30 |
加利福尼亚大学董事会 |
雄激素受体的n-末端结构域的抑制剂
|
US10238626B2
(en)
|
2017-01-23 |
2019-03-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
US10231947B2
(en)
|
2017-01-23 |
2019-03-19 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Isochroman compounds and methods of use thereof
|
US10238655B2
(en)
|
2017-01-23 |
2019-03-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Dihydroindene and tetrahydronaphthalene compounds
|
EP3573957B1
(de)
|
2017-01-24 |
2023-04-26 |
Rivara, Mirko |
Zusammensetzungen und verfahren zur blockierung von natriumkanälen
|
EP3573968A1
(de)
|
2017-01-30 |
2019-12-04 |
Biogen MA Inc. |
Nrf2-aktivator
|
WO2018140738A1
(en)
|
2017-01-30 |
2018-08-02 |
Biogen Ma Inc. |
Nrf 2 activator
|
WO2018148204A1
(en)
|
2017-02-07 |
2018-08-16 |
Biogen Ma Inc. |
Ask1 inhibiting agents
|
WO2018150276A2
(en)
|
2017-02-16 |
2018-08-23 |
Universidad San Sebastian |
The combination of cotinine plus antioxidant for treatment-resistant depression and correction of astrocytes functional deficit induced by depression and other neuropathological conditions
|
CN110770224B
(zh)
|
2017-03-10 |
2022-11-18 |
罗格斯新泽西州立大学 |
作为外排泵抑制剂的吲哚衍生物
|
US11180459B2
(en)
|
2017-03-10 |
2021-11-23 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
US11938114B2
(en)
|
2017-03-10 |
2024-03-26 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
JOP20190233A1
(ar)
|
2017-04-14 |
2019-10-02 |
Biogen Ma Inc |
نظائر بنزوازيبين بوصفها عوامل مثبطة لتيروزين كيناز بروتون
|
US10294264B2
(en)
|
2017-04-21 |
2019-05-21 |
Warsaw Orthopedic, Inc. |
Oxysterol-therapeutic agent derivative for bone healing
|
CA3063174A1
(en)
|
2017-05-12 |
2018-11-15 |
Innovus Pharmaceuticals, Inc. |
Therapeutic methods and compositions
|
US10434106B2
(en)
|
2017-05-19 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Oxysterol-statin compounds for bone growth
|
JP2020520949A
(ja)
|
2017-05-22 |
2020-07-16 |
ユニバーシティ オブ ヴァージニア パテント ファウンデーションUniversity Of Verginia Patent Foundation |
組成物、並びにミトコンドリア脱共役剤を調製及び使用する方法
|
EP3630109A4
(de)
|
2017-05-26 |
2021-03-17 |
Rutgers, the State University of New Jersey |
Inhibitoren für bakterielle abflusspumpen
|
MX2019014400A
(es)
|
2017-06-02 |
2020-02-10 |
Merck Patent Gmbh |
Inmunoglobulinas que se unen a adamts.
|
BR112019025392A2
(pt)
|
2017-06-02 |
2020-07-07 |
Ablynx N.V. |
imunoglobulinas de ligação ao agrecano
|
US20200190216A1
(en)
|
2017-06-02 |
2020-06-18 |
Merck Patent Gmbh |
Mmp13 binding immunoglobulins
|
AU2018277102A1
(en)
|
2017-06-02 |
2019-12-19 |
Ablynx N.V. |
Polypeptides binding ADAMTS5, MMP13 and Aggrecan
|
AR112027A1
(es)
|
2017-06-15 |
2019-09-11 |
Biocryst Pharm Inc |
Inhibidores de alk 2 quinasa que contienen imidazol
|
US11396523B2
(en)
|
2017-06-22 |
2022-07-26 |
University Of Virginia Patent Foundation |
Proton activated atomic medicine
|
ES2968421T3
(es)
|
2017-06-23 |
2024-05-09 |
San Diego State Univ Research Foundation |
Atropisomerismo para la selectividad potenciada de inhibidor de cinasa
|
WO2019005841A1
(en)
|
2017-06-26 |
2019-01-03 |
Rutgers, The State University Of New Jersey |
THERAPEUTIC COMPOUNDS AND METHODS FOR TREATING INFECTION
|
JP7213863B2
(ja)
|
2017-07-12 |
2023-01-27 |
ダート・ニューロサイエンス・エルエルシー |
Pde7阻害剤としての置換ベンゾオキサゾール及びベンゾフラン化合物
|
CN107446050A
(zh)
|
2017-08-11 |
2017-12-08 |
百奥泰生物科技(广州)有限公司 |
Trop2阳性疾病治疗的化合物及方法
|
WO2019046467A1
(en)
|
2017-08-29 |
2019-03-07 |
Rutgers, The State University Of New Jersey |
INDAZOLES THERAPEUTIC
|
WO2019147308A2
(en)
|
2017-08-30 |
2019-08-01 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Rna nanostructures and methods of making and using rna nanostructures
|
EP3691644A4
(de)
|
2017-10-06 |
2021-06-30 |
Blue Therapeutics, Inc. |
Verfahren zur behandlung von akuten oder chronischen schmerzen
|
KR20200070334A
(ko)
|
2017-10-16 |
2020-06-17 |
아라곤 파마슈티컬스, 인코포레이티드 |
비-전이성 거세-저항성 전립선암의 치료를 위한 항-안드로겐
|
US11565094B2
(en)
|
2017-10-17 |
2023-01-31 |
The Methodist Hospital System |
Delivery devices
|
EP3713913A1
(de)
|
2017-11-21 |
2020-09-30 |
Biogen MA Inc. |
Als nrf2-aktivatoren verwendbare tetrahydronaphthalinderivate
|
CA3120971A1
(en)
|
2017-11-27 |
2019-05-31 |
Dart Neuroscience, Llc |
Substituted furanopyrimidine compounds as pde1 inhibitors
|
EP3716956B1
(de)
|
2017-11-29 |
2024-06-26 |
The Cleveland Clinic Foundation |
Antitumor-tet2-modulierende verbindungen
|
CA3083190A1
(en)
|
2017-11-30 |
2019-06-06 |
Cytogel Pharma, Llc |
Novel analgesic pharmaceutical formulations and uses thereof
|
WO2019112885A1
(en)
|
2017-12-07 |
2019-06-13 |
The Cleveland Clinic Foundation |
Treatment of steroid-resistant disease using an anthocyanin and a corticosteroid
|
US11242533B2
(en)
|
2018-01-10 |
2022-02-08 |
Arizona Board Of Regents On Behalf Of Arizona State University |
RNA-nanostructured double robots and methods of use thereof
|
US10738093B2
(en)
|
2018-01-25 |
2020-08-11 |
The Hong Kong University Of Science And Technology |
Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining
|
CN112118837B
(zh)
|
2018-02-13 |
2024-07-09 |
罗格斯新泽西州立大学 |
抗菌剂:o-烷基氘化派洛宁
|
WO2019168688A2
(en)
|
2018-02-15 |
2019-09-06 |
Senhwa Biosciences, Inc. |
Quinolone analogs and their salts, compositions, and method for their use
|
US11890352B2
(en)
|
2018-02-27 |
2024-02-06 |
University Of Virginia Patent Foundation |
Plectin-targeted liposomes/PARP inhibitor in the treatment of cancer
|
US11365191B2
(en)
|
2018-02-28 |
2022-06-21 |
Dart Neuroscience, Llc |
Substituted cyclohexyl compounds as NOP inhibiiors
|
WO2019173507A1
(en)
|
2018-03-06 |
2019-09-12 |
Rutgers, The State University Of New Jersey |
Antibacterial agents : arylalkylcarboxamido phloroglucinols
|
WO2019178267A2
(en)
|
2018-03-13 |
2019-09-19 |
University Of Iowa Research Foundation |
Inductive regeneration of the airway by transcriptional factor modulation of glandular myoepithelial stem cells
|
WO2019178191A1
(en)
|
2018-03-14 |
2019-09-19 |
Biogen Ma Inc. |
O-glycoprotein-2-acetamido-2-deoxy-3-d-glycopyranosidase inhibitors
|
TW202010742A
(zh)
|
2018-04-06 |
2020-03-16 |
美商百歐克斯製藥公司 |
取代的苯并呋喃、苯并吡咯、苯并噻吩及結構相關的補體抑制劑
|
CA3097752A1
(en)
|
2018-04-20 |
2019-10-24 |
Virginia Tech Intellectual Properties, Inc. |
Imidazopyridines useful as mitochondrial uncouplers
|
WO2020036654A2
(en)
|
2018-04-27 |
2020-02-20 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Highly knotted molecular topologies from single-stranded nucleic acids
|
US10899753B2
(en)
|
2018-05-14 |
2021-01-26 |
Biogen Ma Inc. |
Inhibiting agents for Bruton's tyrosine kinase
|
MX2020013895A
(es)
|
2018-06-27 |
2021-07-21 |
Biogen Ma Inc |
Agentes inhibidores de ask1.
|
BR112021000316A2
(pt)
|
2018-07-09 |
2021-04-06 |
Taiwan Liposome Co. Ltd |
Métodos para reduzir complicações de esteroide intra-articular
|
SG11202012464WA
(en)
|
2018-07-11 |
2021-01-28 |
H Lee Moffitt Cancer Center And Research Institute Inc |
Dimeric immuno-modulatory compounds against cereblon-based mechanisms
|
US10898460B1
(en)
|
2018-07-20 |
2021-01-26 |
University Of South Florida |
Leishmania inhibitors
|
WO2020028814A1
(en)
|
2018-08-03 |
2020-02-06 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Allosteric inhibitor of wee1 kinase
|
WO2020036946A1
(en)
|
2018-08-14 |
2020-02-20 |
Biogen Ma Inc. |
Pyridine macrocycle compounds as ask1 inhibiting agents
|
MX2021001783A
(es)
|
2018-08-14 |
2021-08-11 |
Biogen Ma Inc |
Agentes inhibidores de ask1.
|
US11332499B2
(en)
|
2018-08-16 |
2022-05-17 |
Regents Of The University Of Minnesota |
Cyclic peptides and methods of use thereof
|
JP2022500453A
(ja)
|
2018-09-13 |
2022-01-04 |
ミネアムリタ セラピューティクス, エルエルシー |
線維症、nash、及び、nafldを治療する方法での使用のためのトリプトリド、及び、そのプロドラッグ
|
JP2022500472A
(ja)
|
2018-09-19 |
2022-01-04 |
バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. |
O−糖タンパク質−2−アセトアミド−2−デオキシ−3−d−グルコピラノシダーゼ阻害剤
|
JP7476214B2
(ja)
|
2018-10-15 |
2024-04-30 |
バイオジェン・エムエイ・インコーポレイテッド |
ブルトン型チロシンキナーゼ阻害剤の結晶多形
|
US11696957B2
(en)
|
2018-10-17 |
2023-07-11 |
Sunstate Biosciences, LLC |
Single protein-encapsulated pharmaceutics for enhancing therapeutic effects
|
US20220002238A1
(en)
|
2018-11-07 |
2022-01-06 |
Regents Of The University Of Minnesota |
Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction
|
EP3876827B1
(de)
|
2018-11-09 |
2023-09-27 |
The University of Rochester |
Verfahren zur bestimmung einer behandlung von krebs auf basis einer antwortvorhersage mittels lichtstreuungstechnologie
|
CA3120970A1
(en)
|
2018-11-26 |
2020-06-04 |
Denali Therapeutics Inc. |
Methods for treating dysregulated lipid metabolism
|
AR117252A1
(es)
|
2018-12-05 |
2021-07-21 |
Biogen Ma Inc |
Inhibidores de o-glucoproteína-2-acetamido-2-desoxi-3-d-glucopiranosidasa de morfolinilo, piperazinilo, oxazepanilo y diazepanilo
|
AU2020208192A1
(en)
|
2019-01-14 |
2021-08-05 |
Regents Of The University Of Minnesota |
CD200AR ligands for cancer immunotherapy
|
US20220106305A1
(en)
|
2019-02-04 |
2022-04-07 |
Biogen Ma Inc. |
Bicyclic ether o-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors
|
US20220259197A1
(en)
|
2019-03-08 |
2022-08-18 |
Biogen Ma Inc. |
Azetidinyl o-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors
|
WO2020225779A1
(en)
|
2019-05-09 |
2020-11-12 |
Istituto Pasteur Italia - Fondazione Cenci Bolognetti |
Rig-i agonists for cancer treatment and immunotherapy
|
US20220259194A1
(en)
|
2019-05-15 |
2022-08-18 |
Biogen Ma Inc. |
Inhibiting agents for bruton's tyrosine kinase
|
WO2020257658A1
(en)
|
2019-06-20 |
2020-12-24 |
University Of Iowa Research Foundation |
Nanoparticles comprising quinone w methides and compositions for use
|
WO2020263989A1
(en)
|
2019-06-24 |
2020-12-30 |
University Of Iowa Research Foundation |
Jnk inhibitors as anticancer agents
|
BR112022002060A2
(pt)
|
2019-08-06 |
2022-06-07 |
Biocryst Pharm Inc |
Síntese de escala de processo de um inibidor de calicreína de plasma
|
BR112022006739B1
(pt)
|
2019-10-10 |
2024-01-23 |
Cellectar Biosciences, Inc |
Conjugados fosfolipídio-flavagina e métodos de uso do mesmo para terapia direcionada a câncer
|
JP2022553376A
(ja)
|
2019-10-25 |
2022-12-22 |
アクセント・セラピューティクス・インコーポレイテッド |
Mettl3モジュレーター
|
US20230060003A1
(en)
|
2019-10-29 |
2023-02-23 |
Biogen Ma Inc. |
Spirocyclic o-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors
|
US20220411429A1
(en)
|
2019-10-30 |
2022-12-29 |
Biogen Ma Inc. |
Condensed pyridazine or pyrimidine as btk inhibitors
|
JP2023501236A
(ja)
|
2019-10-30 |
2023-01-18 |
バイオジェン・エムエイ・インコーポレイテッド |
ブルトン型チロシンキナーゼに対する阻害剤としての縮合型二複素環
|
WO2021133894A1
(en)
|
2019-12-23 |
2021-07-01 |
Biogen Ma Inc. |
Btk inhibitors
|
US20230053688A1
(en)
|
2020-01-10 |
2023-02-23 |
Cornell University |
Methods to alter latency in ebv+ malignancies
|
WO2021236578A1
(en)
|
2020-05-18 |
2021-11-25 |
Salk Institute For Biological Studies |
Chromen-4-one derivatives, such as e.g. flavones, for use as ck2 inhibitors for the treatment of neuroinflammation
|
TWI776584B
(zh)
|
2020-07-10 |
2022-09-01 |
長庚醫療財團法人林口長庚紀念醫院 |
β-1腎上腺素受體拮抗劑用於製備減少表皮生長因子受體抑制劑誘導的上皮細胞損傷以及抑制癌細胞的組合物之用途
|
US11529335B2
(en)
|
2020-07-31 |
2022-12-20 |
University Of Iowa Research Foundation |
Compositions and methods for treating cancer
|
WO2022032019A1
(en)
|
2020-08-07 |
2022-02-10 |
Biogen Ma Inc. |
Btk inhibitors
|
EP4208455A1
(de)
|
2020-09-02 |
2023-07-12 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Lzk-gerichtete degrader und verfahren zur verwendung
|
AU2021360789A1
(en)
|
2020-10-14 |
2023-06-15 |
Accent Therapeutics, Inc. |
Mettl3 modulators
|
CN117098763A
(zh)
|
2021-01-07 |
2023-11-21 |
渤健马萨诸塞州股份有限公司 |
Tyk2抑制剂
|
KR20230148180A
(ko)
|
2021-02-22 |
2023-10-24 |
리전츠 오브 더 유니버스티 오브 미네소타 |
면역조절제 및 면역조절제 컨쥬게이트
|
TWI796023B
(zh)
|
2021-03-10 |
2023-03-11 |
長庚醫療財團法人 |
藥物組合物及其用途
|
WO2022212893A1
(en)
|
2021-04-02 |
2022-10-06 |
Biogen Ma Inc. |
Combination treatment methods of multiple sclerosis
|
US11780828B2
(en)
|
2021-05-04 |
2023-10-10 |
Regents Of The University Of Minnesota |
Contraceptive compounds and methods
|
CA3217417A1
(en)
|
2021-05-05 |
2022-11-10 |
Kevin M. Guckian |
Compounds for targeting degradation of bruton's tyrosine kinase
|
CA3224994A1
(en)
|
2021-06-22 |
2022-12-29 |
Dana-Farber Cancer Institute, Inc. |
(1h-pyrrolo[2,3-b]pyridin-1-yl)pyrimidin-2-yl-amino-phenyl--acrylamide inhibitors of egfr for use in the treatment of brain tumors
|
WO2022271951A1
(en)
|
2021-06-23 |
2022-12-29 |
University Of Iowa Research Foundation |
Sustained release formulations comprising a selective androgen receptor modulator
|
WO2023283372A1
(en)
|
2021-07-07 |
2023-01-12 |
Biogen Ma Inc. |
Compounds for targeting degradation of irak4 proteins
|
AU2022308734A1
(en)
|
2021-07-07 |
2024-02-22 |
Biogen Ma Inc. |
Compounds for targeting degradation of irak4 proteins
|
KR20240055041A
(ko)
|
2021-09-01 |
2024-04-26 |
더 유나이티드 스테이츠 오브 아메리카, 애즈 레프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬스 앤드 휴먼 서비시즈 |
혼합 계통 키나제 억제제 및 억제제의 사용 방법
|
WO2023081237A1
(en)
|
2021-11-03 |
2023-05-11 |
Regents Of The University Of Minnesota |
Toll-like receptor agonists and antagonists and uses thereof
|
WO2023086521A1
(en)
|
2021-11-10 |
2023-05-19 |
Biogen Ma Inc. |
Btk inhibitors
|
WO2023086575A1
(en)
|
2021-11-12 |
2023-05-19 |
Biogen Ma Inc. |
Btk inhibitors
|
US20240200078A1
(en)
|
2021-11-18 |
2024-06-20 |
Cornell University |
Microrna-dependent mrna switches for tissue-specific mrna-based therapies
|
WO2023130022A2
(en)
|
2021-12-29 |
2023-07-06 |
University Of Iowa Research Foundation |
Cystatin rna compositions for tissue engineering
|
WO2023220046A1
(en)
|
2022-05-10 |
2023-11-16 |
Biogen Ma Inc. |
Tyk2 inhibitors
|
WO2023220049A1
(en)
|
2022-05-10 |
2023-11-16 |
Biogen Ma Inc. |
Crystalline polymorphs of n-methyl-n-((1s,3s)-3-methyl-3-((6-(1-methyl-1h-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl)oxy)cyclobutyl)acrylamide
|
WO2024006493A1
(en)
|
2022-07-01 |
2024-01-04 |
Biogen Ma Inc. |
Tyk2 inhibitors
|
WO2024006977A1
(en)
|
2022-07-01 |
2024-01-04 |
University Of Southern California |
Analgesic delta opioid receptor bitopic ligands
|
WO2024009283A1
(en)
|
2022-07-07 |
2024-01-11 |
University Of Southern California |
At2 antagonists for non-addictive pain relief
|
WO2024011214A1
(en)
|
2022-07-08 |
2024-01-11 |
Actio Biosciences, Inc. |
Therapeutic compounds and methods
|
WO2024100093A1
(en)
|
2022-11-09 |
2024-05-16 |
Merck Patent Gmbh |
Toll-like receptor 7 agonists as immune-stimulators to elicit the innate antitumor immunity
|
WO2024112932A1
(en)
|
2022-11-23 |
2024-05-30 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
WO2024124023A2
(en)
|
2022-12-07 |
2024-06-13 |
Rutgers, The State University Of New Jersey |
Carbonic anhydrase enzyme inhibitors and methods of use thereof
|